Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD: Azimilide in ICD Patients
NCT00035490Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of azimilide in ventricular tachycardia (VT), ventricular fibrillation (VF), sponsored by Forest Laboratories. Started Sep 2001; status: completed.
02
Drugs
azimilide
03
Conditions
ventricular tachycardia (VT)ventricular fibrillation (VF)
Beyond the preview
Go deeper on NCT00035490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035490.